Key Drivers
- Margin Improvement
- Strong Cash Flow
- Liquidity Pressure
AIAI Summary
LFST has evolved into an operating-leverage and free-cash-flow story, but after its sharp rerating investors should be selective: upside depends on sustaining mid-teen visit growth and expanding margins through the EHR rollout, while any payer, labor, or implementation-driven slowdown could expose a demanding valuation.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Margin Improvement
- •Strong Cash Flow
- •Liquidity Pressure
LFST shows improving quarterly margins and strong cash flow, but historically thin profitability, weakening liquidity, intangible-heavy assets, and a demanding valuation warrant caution.
Price Behavior
Key Price Behavior Insights:
- •Recent pullback
- •Support holding
- •Resistance capped
LFST is neutral-to-cautious after pulling back 6% from $13.38, with traders watching for a rebound from $12.15–$12.30 support or a breakout above $13.38.
6% decline from the $13.38 peak to $12.57
Sentiment & News
Key News Insights:
- •52-Week High
- •New Institutional Stakes
- •Secondary Share Sale
LifeStance's strong share momentum and rising institutional interest are tempered by a large secondary sale that adds no new company capital.
Positive investor visibility supports sentiment, but the secondary offering may create near-term share-price pressure
Similar Companies in Healthcare
Other companies in the same sector with AI ratings